Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of Thomas Riga as Chief Business Officer, effective January 1, 2026.
Yahoo Finance

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

DUBLIN and DURHAM, N.C., March 5, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz" or the "Company") and Chimerix (Nasdaq: CMRX) ("Chimerix"), today announced the companies have ...
Seeking Alpha

Chimerix: Dangerous Road, Thesis Intact

Chimerix meets financial expectations during Q2, 2023 earnings call. Investment thesis for Chimerix focuses on its ONC201 study expected to read out in 2026. Company has high risk of loss despite ...
Insider Monkey

Here’s Why Chimerix, Inc. (CMRX) Is Skyrocketing

We recently compiled a list of the Why These 24 Stocks Are Skyrocketing. In this article, we are going to take a look at where Chimerix, Inc. (NASDAQ:CMRX) stands against the other stocks. One of the ...
MarketWatch

Chimerix stock surges after deal to sell smallpox treatment Tembexa for up to $337.5 million, plus royalties

Shares of Chimerix Inc. shot up 14.4% in premarket trading Monday, after the biopharmaceutical company said it will sell exclusive rights to its smallpox treatment, including Tembexa, to Emergent ...
FierceBiotech

Chimerix Reaffirms its Commitment to CMX001 as a Medical Countermeasure and Broad-Spectrum Antiviral Agent

- Small Business Administration Rules that SIGA Technologies is Not a Small Business, Rendering It Ineligible for BARDA Contract RESEARCH TRIANGLE PARK, NC, November 7, 2010 - Chimerix, Inc., a ...
PE Hub

Confirmed: Chimerix’s $45 Million Fundraising

DURHAM, NC, February 14, 2011 – Chimerix, Inc., a pharmaceutical company developing orally-available broad spectrum antiviral therapeutics, today announced the completion of a $45 million Series F ...